Dextrin conjugation to colistin inhibits its toxicity, cellular uptake and acute kidney injury in vivo.
Varache, M.; Rizzo, S.; Sayers, E. J.; Newbury, L.; Mason, A.; Liao, C.-T.; Chiron, E.; Bourdiec, N.; Jones, A.; Fraser, D. J.; Taylor, P. R.; Jones, A. T.; Thomas, D. W.; Ferguson, E. L.
Show abstract
The acute kidney injury (AKI) and dose-limiting nephrotoxicity, which occurs in 20-60% of patients following systemic administration of colistin, represents a challenge in the effective treatment of multi-drug resistant gram-negative infections. To reduce clinical toxicity of colistin and improve targeting to infected /inflamed tissues, we previously developed dextrin-colistin conjugates, whereby colistin is designed to be released by amylase-triggered degradation of dextrin in infected and inflamed tissues, after passive targeting by the enhanced permeability and retention effect. Whilst it was evident in vitro that polymer conjugation can reduce toxicity and prolong plasma half-life, without significant reduction in antimicrobial activity of colistin, it was unclear how dextrin conjugation would alter cellular uptake and localisation of colistin in renal tubular cells in vivo. We discovered that dextrin conjugation effectively reduced colistins toxicity towards human kidney proximal tubular epithelial cells (HK-2) in vitro, which was mirrored by significantly less cellular uptake of Oregon Green (OG)-labelled dextrin-colistin conjugate, when compared to colistin. Using live-cell confocal imaging, we revealed localisation of both, free and dextrin-bound colistin in endolysosome compartments of HK-2 and NRK-52E cells. Using a murine AKI model, we demonstrated dextrin-colistin conjugation dramatically diminishes both proximal tubular injury and renal accumulation of colistin. These findings reveal new insight into the mechanism by which dextrin conjugation can overcome colistins renal toxicity and show the potential of polymer conjugation to improve the side effect profile of nephrotoxic drugs. Graphical abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=126 SRC="FIGDIR/small/565265v1_ufig1.gif" ALT="Figure 1"> View larger version (42K): org.highwire.dtl.DTLVardef@1ec6ac8org.highwire.dtl.DTLVardef@56a2b1org.highwire.dtl.DTLVardef@1d347fborg.highwire.dtl.DTLVardef@1ab7da_HPS_FORMAT_FIGEXP M_FIG C_FIG
Matching journals
The top 12 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Nephrotoxicity of Calcineurin Inhibitors in kidney epithelial cells is independent of Calcineurin and NFAT signaling. 92%
- CETP inhibitor evacetrapib enters mouse brain tissue 91%
- Low-dose fluvoxamine modulates endocytic trafficking of SARS-CoV-2 spike protein: a potential mechanism for anti-COVID-19 protection by antidepressants 90%
Similar papers in this journal
- Orally delivered biodegradable targeted inflammation resolving pectin-coated nanoparticles induce anastomotic healing post intestinal surgery 92%
- Systemic gene therapy with thymosin β4 alleviates glomerular injury in mice 92%
- Bridging the gap between in silico and in vivo: modeling opioid disposition in a kidney proximal tubule microphysiological system 92%
Similar papers in this journal
- NRF2 upregulation by CDDO-Me protects AC16 human cardiomyocytes against doxorubicin-induced toxicity. 91%
- Advancing Liver Gene Therapy: Enhanced Transduction with GalNAc-Bioconjugated rAAV Capsids 91%
- Ultrafast tyrosine-based cell membrane modification via diazonium salts: a new frontier for biomedical applications 91%
Similar papers in this journal
- Polymer microparticles prolong delivery of the 15-PGDH inhibitor SW033291 92%
- Improved bioavailability of montelukast through a novel oral mucoadhesive film in humans and mice 92%
- Mechanistic Insights into Sphingomyelin Nanoemulsions as Drug Delivery Systems for Non-Small Cell Lung Cancer Therapy 92%
Similar papers in this journal
- Impact of nephrotoxins and oxidants on survival and transport function of hiPSC-derived renal proximal tubular cells 91%
- Tat_BioV: Tattoo ink exposure and biokinetics of selected tracers in a short-term quasi-experimental clinical study of 24 subjects 90%
- Mutagenic and carcinogenic potency determinations for NDMA support the cumulative dose assumption underpinning the less-than-lifetime Threshold of Toxicological Concern 87%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.